Title: The Impact of Probiotic Supplementation on Gastric Motility and Nutrient Absorption in
Elderly Patients with Gastrointestinal Disorders
Version: 1 Date: 26 Jan 2025
Reviewer:  Qiaochu Liang
Reviewer's report:
The revised manuscript has added explanations to issues identified in the previous version. A
few more adjustments are suggested:
1. Please include the statistical methods used for each table and figure in their respective legends.
2. The added text in 2.3 states: “The probiotic administered was LGG (Culturelle®, I-Health Inc.,
USA), given at a dosage of 1 × 1010 colony-forming units (CFU) twice daily, which represents
a modified dosing regimen specifically chosen for this elderly population based on previous
clinical evidence”. Please reference the “previous clinical evidence” if published. If not, please
revise to indicate that it is unpublished preliminary evidence.
3. Authors acknowledged in Sections 3.2, 3.3, and 3.4 of the revised version that before-and-
after changes in the NPS group suggest “potential confounders or natural variations”. Please
expand on the discussion for “potential confounders or natural variations”.
Title: The Impact of Probiotic Supplementation on Gastric Motility and Nutrient Absorption in
Elderly Patients with Gastrointestinal Disorders
Version: 1 Date: 26 Jan 2025
Reviewer:  Qiaochu Liang
Reviewer's report:
The revised manuscript has added explanations to issues identified in the previous version. A
few more adjustments are suggested:
1. Please include the statistical methods used for each table and figure in their respective legends.
2. The added text in 2.3 states: “The probiotic administered was LGG (Culturelle®, I-Health Inc.,
USA), given at a dosage of 1 × 1010 colony-forming units (CFU) twice daily, which represents
a modified dosing regimen specifically chosen for this elderly population based on previous
clinical evidence”. Please reference the “previous clinical evidence” if published. If not, please
revise to indicate that it is unpublished preliminary evidence.
3. Authors acknowledged in Sections 3.2, 3.3, and 3.4 of the revised version that before-and-
after changes in the NPS group suggest “potential confounders or natural variations”. Please
expand on the discussion for “potential confounders or natural variations”.
Please review this paper.
user
Title: The Impact of Probiotic Supplementation on Gastric Motility and Nutrient Absorption in
Elderly Patients with Gastrointestinal Disorders
Version: 1 Date: 26 Jan 2025
Reviewer:  Qiaochu Liang
Reviewer's report:
The revised manuscript has added explanations to issues identified in the previous version. A
few more adjustments are suggested:
1. Please include the statistical methods used for each table and figure in their respective legends.
2. The added text in 2.3 states: “The probiotic administered was LGG (Culturelle®, I-Health Inc.,
USA), given at a dosage of 1 × 1010 colony-forming units (CFU) twice daily, which represents
a modified dosing regimen specifically chosen for this elderly population based on previous
clinical evidence”. Please reference the “previous clinical evidence” if published. If not, please
revise to indicate that it is unpublished preliminary evidence.
3. Authors acknowledged in Sections 3.2, 3.3, and 3.4 of the revised version that before-and-
after changes in the NPS group suggest “potential confounders or natural variations”. Please
expand on the discussion for “potential confounders or natural variations”.
assistant